Contributing Experts

April 28, 2015

Jame Abraham, MD, FACP

Dr. Jame Abraham is the director of the Breast Oncology Program at the Taussig Cancer Institute, and co-director of the Comprehensive Breast Cancer Program at Cleveland Clinic.

Dr. Abraham earned his medical degree from Calicut Medical College in India. He completed his residency at the University of Connecticut, School of Medicine followed by a fellowship in medical oncology at the National Cancer Institute (NCI) and in hematology at the National Heart, Lung, and Blood Institute (NHLBI) of the National Institutes of Health (NIH) in Bethesda Maryland.

At the Case Comprehensive Cancer Center, Dr. Abraham is the co-principal investigator of the Lead Academic Participating Site (LAPS) grant, an essential component of the NCI’s new clinical trials network (CTN). He is the National Surgical Adjuvant Bowel and Breast Project (NSABP) principal investigator for Cleveland Clinic. In addition, he is vice chair of the Research Review Committee for the NSABP Foundation and a member of the NSABP Scientific Advisory Board. Dr. Abraham is also a member of the Breast Cancer Research Committee, part of the newly formed NRG (NSABP/RTOG/GOG) Oncology group.

He is the founding Chair of the Cleveland Clinic online tumor board series which is published by Harborside Press, (New York). Dr. Abraham is the founding editor of the Bethesda Handbook of Clinical Oncology by Lippincott Williams and Wilkins (Philadelphia), one of the best-selling oncology textbooks in the world. He was the chief editor of the Emerging Cancer Therapeutics series by Demos publication (New York). In addition, he is one of the editors of the Journal of Supportive and Community Oncology of Frontline Communications (New Jersey). Dr. Abraham has more than 100 scientific papers and abstracts that have been accepted by many national meetings and journals, including the Journal of Clinical Oncology, Journal of National Cancer Institute, Annals of Internal Medicine, Cancer and Bone Marrow Transplantation, and Clinical Cancer Research.

Dr. Abraham currently holds two patents; one titled System and Device for Tumor Characterization Using Nonlinear Elastography Imaging (2014) and one on risk stratification of patients with breast cancer.

He has received several awards including, the Dean’s Award for Excellence in Clinical Medicine (2010), Outstanding Faculty Award (2007) and Clinician of the Year Award (2006) from West Virginia University. The President of India presented him with an award for his Contributions in Medicine (nominated by Pazhassi Raja Trust, 2009). He also received the Volunteer of Year Award, from the American Cancer Society, WV (2007).

He is a past member of the NSABP breast committee (2002-2014) and member of the Breast Cancer Working Committee of the NSABP (2010-2014). He also served on the Board of Directors for the American Cancer Society - South Atlantic Division (2007-2010).

Before joining Cleveland Clinic, Dr. Abraham was the first Bonnie Wells Wilson Distinguished Professor and Eminent Scholar in breast cancer research, Professor of medicine and Section Chief of hematology oncology at West Virginia University.

Last Updated: April 28, 2015

Sign up for

My RxWiki  &   RxWiki Notify

Follow the medications that matter most to
you and Ask related questions.

Receive email notifications as soon as your
medication pages are updated.

Jame Abraham, MD, FACP Insights